First Midwest Bank Trust Division’s Karyopharm Therapeutics KPTI Stock Holding History

First Midwest Bank Trust Division’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-827	Closed	-$192K	–	385
2020 Q4	$192K	Hold	827	–	–	0.03%	349
2020 Q3	$181K	Sell	827 -827	-50%	-$202K	0.03%	346
2020 Q2	$470K	Hold	1,654	–	–	0.08%	239
2020 Q1	$477K	Hold	1,654	–	–	0.09%	220
2019 Q4	$476K	Sell	1,654 -1,667	-50%	-$362K	0.06%	261
2019 Q3	$479K	Sell	3,321 -26,079	-89%	-$3.54M	0.07%	265
2019 Q2	$2.64M	Sell	29,400 -11,323	-28%	-$909K	0.38%	67
2019 Q1	$3.57M	Buy	40,723 +29,384	+259%	+$3.26M	0.49%	52
2018 Q4	$1.59M	Buy	+11,339	New	+$1.91M	0.24%	112

Other funds holding KPTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

First Midwest Bank Trust Division's KPTI Position: Q1 2021 in Review

First Midwest Bank Trust Division sold out of Karyopharm Therapeutics (KPTI) in Q1 2021, closing a stake of 827 shares — an estimated $192K sold.

First Midwest Bank Trust Division first reported a position in KPTI in Q4 2018 and held it in 9 quarters. The position peaked at $3.57M in Q1 2019. 171 funds tracked by Wall St. Rank hold KPTI as of Q1 2021.

First Midwest Bank Trust Division reported no remaining Karyopharm Therapeutics position as of Q1 2021 after selling out during the quarter.
First Midwest Bank Trust Division sold 827 Karyopharm Therapeutics shares in Q1 2021, an estimated $192K.
First Midwest Bank Trust Division first reported a position in Karyopharm Therapeutics in Q4 2018 and held it in 9 quarters.
First Midwest Bank Trust Division's Karyopharm Therapeutics position peaked at $3.57M in Q1 2019.
171 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q1 2021, filed 15 Apr 2021.